Stamford, CT -- (SBWIRE) -- 12/09/2013 -- Wall Street Pennies is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: Camtek LTD. (NASDAQ:CAMT), Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Provectus Pharmaceuticals, Inc. (OTCMKTS:PVCT), Hewlett-Packard Company (NYSE:HPQ).
Camtek LTD. (NASDAQ:CAMT) opened its last trade at the price of $4.50. Its closing price was $4.30 after losing -1.44% for the day. The company traded with the total volume of 1.81 million shares, while its average trading volume remained 3.18 million shares. The beta of this stock stands at 1.90. Camtek Ltd., together with its subsidiaries, designs, develops, manufactures, and markets automatic optical inspection (AOI) systems and related products. AOI systems are computerized systems that optically inspect various types of electronic product components for defects caused during the manufacturing process.
Has CAMT Found The Bottom and Ready To Move Up? Find Out Here
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) percentage change plunged -4.03% to close at $5.95 with the total traded volume of 4.83 million shares, along with average volume of 6.05 million shares. The 52 week range of the stock remained $4.05 - $11.00, while its day lowest price was $5.90. The share price hit the day highest price of $6.26. Arena Pharmaceuticals, Inc., a biopharmaceutical company, engages in discovering, developing, and commercializing novel drugs that target G protein-coupled receptors in the therapeutic areas of cardiovascular, central nervous system, inflammatory, and metabolic diseases.
Has ARNA Found The Bottom And Ready To Gain Momentum? Find Out Here
Provectus Pharmaceuticals, Inc. (OTCMKTS:PVCT) traded on volume of 1.24 million shares in the last session against average volume of 474,001.00 shares. The company started its trading session with the price of $0.99 and closed at $0.994 by scoring +1.43%. Provectus Pharmaceuticals, Inc., a development-stage pharmaceutical company, engages in developing pharmaceuticals for oncology and dermatology indications. The company’s product line includes PV-10, a Phase II study completed drug candidate for metastatic melanoma.
Will PVCT Continue To Move Higher? Find Out Here
Hewlett-Packard Company (NYSE:HPQ) started its last trading session with the price of $27.61 and closed at $27.70 by scoring +1.65%. The stock traded with total volume of 17.18 million shares, while the average trading volume remained 17.11 million shares. The beta value of this stock stands at 1.42. Day range for the stock was $27.59 - $28.11. Hewlett-Packard Company and its subsidiaries provide products, technologies, software, solutions, and services to individual consumers, small-and medium-sized businesses (SMBs), and large enterprises, including customers in the government, health, and education sectors worldwide.
Why Should Investors Buy HPQ After The Recent Gain? Just Go Here and Find Out
About Wall Street Pennies:
Wall Street Pennies is always penetrating the market every day for enormous penny stock runs before they happen in order to assist its customers. Our Penny Stock Newsletter also offers free market strategies and analysis from one of the most experienced and well-respected chartists in the penny stock industry.
Carriage Consulting Group, www.wallstreetpennies.com,, their Members, officers, directors, employees, affiliates, or any other related person(s) (collectively, “www.wallstreetpennies.com,”) are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. Wall Street Pennies as defined are neither licensed nor qualified to provide investment advice and you are specifically and adamantly advised not to rely upon anything said/posted/communicated/implied or expressed by www.wallstreetpennies.com, as defined.
Read full Disclaimer at: http://wallstreetpennies.com/financial-disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)